Von Hippel-Lindau disease: a genetic study.

E R Maher, L Iselius, J R Yates, M Littler, C Benjamin, R Harris, J Sampson, A Williams, M A Ferguson-Smith and N Morton

Cambridge University, Department of Pathology.

Genetic aspects of von Hippel-Lindau (VHL) disease were studied in familial and isolated cases. Complex segregation analysis with pointers was performed in 38 kindreds with two or more affected members. Dominant inheritance with almost complete penetrance in the highest age classes (0.96 at 51 to 60 and 0.99 at 61 to 70 years) was confirmed and there was no evidence of heterogeneity between families ascertained through complete and incomplete selection. The point prevalence of heterozygotes in East Anglia was 1.89/100,000 (1/53,000) persons with an estimated birth incidence of 2.73/100,000 (1/36,000) live births. Reproductive fitness was 0.83. Direct and indirect estimates of the mutation rate were 4.4 (95% CI 0.9 to 7.9) x 10(-6)/gene/generation and 2.32 x 10(-6)/gene/generation respectively. There was no significant association between parental age or birth order and new mutations for VHL disease.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Risk of multisystem disease in isolated ocular angioma (haemangioblastoma)

ANDREW R WEBSTER, EAMONN R MAHER, ALAN C BIRD, and ANTHONY T MOORE
J. Med. Genet. 2000 37: 62-63. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Vanneste, E., Melotte, C., Debrock, S., D'Hooghe, T., Brems, H., Fryns, J.P., Legius, E., Vermeesch, J.R. (2009). Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions. Hum Reprod 24: 1522-1528 [Abstract] [Full Text]  
• Kehrer-Sawatzki, H, Cooper, D N (2008). Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?. J. Med. Genet. 45: 622-631 [Abstract] [Full Text]  
• Butman, J. A., Linehan, W. M., Lonser, R. R. (2008). Neurologic Manifestations of von Hippel-Lindau Disease. JAMA 300: 1334-1342 [Abstract] [Full Text]  
• Hiles, J. J., Kolesar, J. M. (2008). Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma. Am J Health Syst Pharm 65: 123-131 [Abstract] [Full Text]  
• Karagiannis, A., Mikhailidis, D. P, Athyros, V. G, Harsoulis, F. (2007). Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14: 935-956 [Abstract] [Full Text]  
• Wong, W. T., Agron, E., Coleman, H. R., Reed, G. F., Csaky, K., Peterson, J., Glenn, G., Linehan, W. M., Albert, P., Chew, E. Y. (2007). Genotype-Phenotype Correlation in von Hippel-Lindau Disease With Retinal Angiomatosis. Arch Ophthalmol 125: 239-245 [Abstract] [Full Text]  
• Jimenez, C., Cote, G., Arnold, A., Gagel, R. F. (2006). Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes?. J. Clin. Endocrinol. Metab. 91: 2851-2858 [Abstract] [Full Text]  
• Woodward, E. R, Maher, E. R (2006). Von Hippel-Lindau disease and endocrine tumour susceptibility.. Endocr Relat Cancer 13: 415-425 [Abstract] [Full Text]  
• Maher, E. R. (2006). Genetics of phaeochromocytoma. Br Med Bull 79-80: 141-151 [Abstract] [Full Text]  
• Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., Nathanson, K. L. (2003). Pheochromocytoma: The Expanding Genetic Differential Diagnosis. JNCI J Natl Cancer Inst 95: 1196-1204 [Abstract] [Full Text]  
• Rocha, J C C, Silva, R L A, Mendonca, B B, Marui, S, Simpson, A J G, Camargo, A A (2003). High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J. Med. Genet. 40: e31-31 [Full Text]  
• Choyke, P. L., Glenn, G. M., Walther, M. M., Zbar, B., Linehan, W. M. (2003). Hereditary Renal Cancers. Radiology 226: 33-46 [Abstract] [Full Text]  
• Cybulski, C, Krzystolik, K, Murgia, A, Gorski, B, Debniak, T, Jakubowska, A, Martella, M, Kurzawski, G, Prost, M, Kojder, I, Limon, J, Nowacki, P, Sagan, L, Bialas, B, Kaluza, J, Zdunek, M, Omulecka, A, Jaskolski, D, Kostyk, E, Koraszewska-Matuszewska, B, Haus, O, Janiszewska, H, Pecold, K, Starzycka, M, Slomski, R, Cwirko, M, Sikorski, A, Gliniewicz, B, Cyrylowski, L, Fiszer-Maliszewska, L, Gronwald, J, Toloczko-Grabarek, A, Zajaczek, S, Lubinski, J (2002). Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J. Med. Genet. 39: e38-38 [Full Text]  
• Allen, R. C., Webster, A. R., Sui, R., Brown, J., Taylor, C. M., Stone, E. M. (2001). Molecular Characterization and Ophthalmic Investigation of a Large Family With Type 2A von Hippel-Lindau Disease. Arch Ophthalmol 119: 1659-1665 [Abstract] [Full Text]  
• Friedrich, C. A. (2001). Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10: 763-767 [Abstract] [Full Text]  
• Niemelä, M., Mäenpää, H., Salven, P., Summanen, P., Poussa, K., Laatikainen, L., Jääskeläinen, J., Joensuu, H. (2001). Interferon {{alpha}}-2a Therapy in 18 Hemangioblastomas. Clin. Cancer Res. 7: 510-516 [Abstract] [Full Text]  
• Singh, A. D., Shields, J. A., Shields, C. L. (2001). Solitary Retinal Capillary Hemangioma: Hereditary (von Hippel-Lindau Disease) or Nonhereditary?. Arch Ophthalmol 119: 232-234 [Abstract] [Full Text]  
• Hes, F J, McKee, S, Taphoorn, M J B, Rehal, P, van der Luijt, R B, McMahon, R, van der Smagt, J J, Dow, D, Zewald, R A, Whittaker, J, Lips, C J M, MacDonald, F, Pearson, P L, Maher, E R (2000). Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only. J. Med. Genet. 37: 939-943 [Abstract] [Full Text]  
• Niemelä, M., Lemeta, S., Sainio, M., Rauma, S., Pukkala, E., Kere, J., Böhling, T., Laatikainen, L., Jääskeläinen, J., Summanen, P. (2000). Hemangioblastomas of the Retina: Impact of von Hippel-Lindau Disease. IOVS 41: 1909-1915 [Abstract] [Full Text]  
• WEBSTER, A. R, MAHER, E. R, BIRD, A. C, MOORE, A. T (2000). Risk of multisystem disease in isolated ocular angioma (haemangioblastoma). J. Med. Genet. 37: 62-63 [Full Text]  
• Roach, E. S. (1999). Von Hippel-Lindau disease. Neurology 53: 7-7 [Full Text]  
• Webster, A. R., Maher, E. R., Moore, A. T. (1999). Clinical Characteristics of Ocular Angiomatosis in von Hippel-Lindau Disease and Correlation With Germline Mutation. Arch Ophthalmol 117: 371-378 [Abstract] [Full Text]  
• Schoenfeld, A., Davidowitz, E. J., Burk, R. D. (1998). A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc. Natl. Acad. Sci. USA 95: 8817-8822 [Abstract] [Full Text]  
• Webster, A. R, Fisher, R. B, Ginsberg, L., Maher, E. R (1997). Independent segregation of von Hippel-Lindau disease and cerebral cavernomas. J. Neurol. Neurosurg. Psychiatry 63: 665-668 [Abstract] [Full Text]  
• Eng, C. (1996). The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease. NEJM 335: 943-951 [Full Text]  
• Linehan, W. M., Lerman, M. I., Zbar, B. (1995). Identification of the von Hippel-Lindau (VHL) Gene: Its Role in Renal Cancer. JAMA 273: 564-570 [Abstract]  
• Gagel, R. F., Neumann, H. P.H. (1994). Pheochromocytoma, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease. NEJM 330: 1090-1091 [Full Text]  
• Latif, F, Tory, K, Gnarra, J, Yao, M, Duh, F., Orcutt, M., Stackhouse, T, Kuzmin, I, Modi, W, Geil, L, et, al. (1993). Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317-1320 [Abstract]  
• Glenn, G. M., Linehan, W. M., Hosoe, S., Latif, F., Yao, M., Choyke, P., Gorin, M. B., Chew, E., Oldfield, E., Manolatos, C., Orcutt, M. L., Walther, M. M., Weiss, G. H., Tory, K., Jensson, O., Lerman, M. I., Zbar, B. (1992). Screening for von Hippel-Lindau Disease by DNA Polymorphism Analysis. JAMA 267: 1226-1231 [Abstract]